I-Mab
IMABNASDAQHealthcare
$2.88
$-0.02(-0.69%)
Market Cap$542009454
P/E Ratio—
52W High$6.79
52W Low$0.595
I-Mab（IMAB）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · IMAB · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | ($0.01B) | $0.09B | $1.54B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.05B | $0.00B |
| Gross Profit | $0.00B | $0.00B | ($0.01B) | $0.04B | $1.54B |
| Gross Margin %(computed) | — | 100.00% | 100.00% | 47.25% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $0.02B | $0.11B | $0.16B | $0.19B | $0.98B |
| G&A Expenses | $0.03B | $0.06B | $0.20B | $0.90B | $0.40B |
| Total Operating Expenses | $0.05B | $0.52B | $0.36B | $2.11B | $1.39B |
| Operating Income | ($0.05B) | ($0.51B) | ($0.37B) | ($2.07B) | $0.16B |
| Operating Margin %(computed) | — | — | — | — | 10.08% |
| Interest Income | $0.01B | $0.01B | $0.00B | $0.02B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.05B) | ($1.47B) | ($0.97B) | ($2.33B) | $0.48B |
| Income Tax Expense | $0.00B | ($1.26B) | $0.00B | ($0.00B) | $0.01B |
| Net Income | ($0.02B) | ($1.47B) | ($2.51B) | ($2.33B) | $0.47B |
| Net Margin %(computed) | — | — | — | — | 30.53% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.62 | $-17.62 | $-30.38 | $-30.70 | $8.07 |
| Wtd Avg Shares | 0.08B | 0.08B | 0.08B | 0.08B | 0.07B |
| EBITDA | ($0.05B) | ($0.34B) | ($0.05B) | ($2.06B) | $0.17B |
| EBITDA Margin %(computed) | — | — | 478.91% | — | 10.91% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解I-Mab
关于I-Mab（IMAB）损益表
I-Mab（IMAB）损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年，IMAB实现营收$0.00B，毛利润$0.00B（毛利率—），净利润($0.02B)（净利率—）。
常见问题
IMAB · 4 问I-Mab（IMAB）2024财年营收为$0.00B，同比down100.0%。
IMAB revenueIMAB salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08